Tag: Antipsychotics
Anticholinergic Psychiatric Drugs Linked to a 50% Increase in Dementia
People who take anticholinergic drugs, such as antidepressants and antipsychotics, are at a 50% higher risk of dementia.
Better Outcomes Off Medication for Those Recovered from First-Episode Schizophrenia
A new study has found that of 10 people who were fully recovered from their first episode of schizophrenia (FES), those not taking antipsychotics did better in terms of cognitive, social, and role functioningâand reached full recovery more quickly.
Antipsychotics Associated with High Risk of Death in Children
A new study has found that children and adolescents taking a high dose of antipsychotics are almost twice as likely to die of any cause than children on other types of medications.
Researchers Warn of âBrain Atrophyâ in Children Prescribed Antipsychotics
Researchers discuss the evidence that antipsychotic medications may cause brain atrophy in children, whose brains are still developing.
Gradual Tapering is Most Successful for Withdrawal from Antipsychotics
Mixed-Methods study explores the experiences of antipsychotic discontinuation among service users.
Two-Thirds of Schizophrenia Patients Do Not Remit on Antipsychotics
A new analysis of antipsychotic treatment of schizophrenia (published in Schizophrenia Bulletin) has found that two-thirds of patients treated this way do not experience symptom remission.
New Review of Antipsychotics for Schizophrenia Questions Evidence for Long Term...
A systematic review of the limited research available on the long-term effects of antipsychotics finds fewer symptoms in those off of the drugs.
New Research on Patient-Centered Deprescribing for Antipsychotics
Researchers review the risks and benefits of deprescribing from antipsychotic drugs and advocate for a patient-centered approach to tapering.
Study Shows Success With Reduced Antipsychotic Use
People who reduced antipsychotic use by tapering were doing just as well after five years as those who continued using the drugs.
Study Reduces Over-prescription of Antipsychotics in Older Adults
New intervention shows promise in reducing over-prescription of off-label antipsychotics in older adults.
Challenges for the Next Phase of Integrated Medicaid Care in OR
From The Lund Report: "Access to the current disease-centered system of mental health care will almost certainly mean worse outcomes for many people than if...
His Lovely Wife in the Psych Ward (Podcast)
From Psychiatric Times: "After the first episode, when Giulia was healthy and balanced and stable in between, she was really mad at me, and I...
Patients’ Drug Options Under Medicaid Influenced by Drugmakers
From NPR: "A Center for Public Integrity and NPR investigation found drug companies have infiltrated nearly every part of the process that determines how their drugs will be covered...
New Research Suggests Brain Abnormalities in âSchizophreniaâ May Result From Antipsychotics
Study finds that reduced cortical thickness and brain surface area associated with 'schizophrenia' may result from antipsychotic drug use.
FDA Repays Industry by Rushing Risky Drugs to Market
From ProPublica:Â "The FDA is increasingly green-lighting expensive drugs despite dangerous or little-known side effects and inconclusive evidence that they curb or cure disease. Once...
FDA Defends Decision to Approve Digital Aripiprazole
Members of the U.S. Food and Drug Administrationâs Psychiatry Products division go on the defensive in a new article, responding to concerns about the agencyâs approval of digital aripiprazole.
“The Angry Consumer”: Embracing Difficult Conversations
Judgments of the so-called âangry consumerâ deeply reinforce divisions within mental health policy and services. The only way we can engage in meaningful co-production is not to gloss over histories of collective exclusion and disempowerment and all the pain and anger that goes with it, but rather to validate and work through difficult emotions.
Children on Antipsychotics at Risk for Weight Gain and Diabetes
From U.S. News: "Children and adolescents treated with antipsychotic medications experience weight gain and develop an increased risk of diabetes, according to a new...
Royal College of Psychiatrists Accused of Misleading Claims
From The Herald: A group of mental health experts and patients have submitted a formal letter of complaint accusing the Royal College of Psychiatrists of...
For-Profit Medicine Incentivizes Overmedicating Our Elderly
From NBC: According to human rights investigators, anti-psychotic drugs are often administered to nursing home residents to address behavioral issues. Our nation's lack of funding...
Care Homes Over-Prescribing Drugs for Residents with Dementia
From The Guardian: According to a new Human Rights Watch report, U.S. nursing homes are inappropriately prescribing antipsychotics to an estimated 179,000 residents with dementia each...
Psychiatry is a Disaster Area in Healthcare That Needs Attention
In this piece for The BMJ, Dr. Peter Gøtzsche points out several of the major problems with the drug-based paradigm of psychiatric care as well as...
Antipsychotics, Restraints, and Seclusion Raising Concerns
From ABC Australia: Australia's high rate of antipsychotic prescriptions, as well as the frequent usage of restraints and seclusion, has raised concerns among Australian mental health advocates, researchers,...
Reexamining Schizophrenia as a Brain Disease
Schizophrenia has occupied, and continues to occupy, a position of great import in psychiatry, and it is frequently used to assert the supposed biological nature of the field. What evidence is there to suggest that what we call schizophrenia is a disease of the brain? Surprisingly, very little.
Patients on Antipsychotics at High Risk for Cardiovascular Issues, Study Finds
Antipsychotics present a known risk for major side effects. A new study suggests that certain antipsychotics may present a greater risk for cardiovascular disease than others.